Upstream / Downstream
Explore pathways related to this product.
CST Antibody Performance Guarantee
To Purchase # 9656S
|9656S||1 Kit (100 tests)||$609.00|
|$ 0. 00|
Find answers on our FAQs page.
PTM information and tools available.
StemLight™ Pluripotency Antibody Kit #9656
|Oct-4A (C30A3) Rabbit mAb||100 tests||IF-IC||1:200||Rabbit IgG|
|Sox2 (D6D9) Rabbit mAb||100 tests||IF-IC||1:200||Rabbit IgG|
|Nanog Antibody||100 tests||IF-IC||1:200||Rabbit IgG|
|SSEA4 (MC813) Mouse mAb||100 tests||IF-IC||1:200||Mouse IgG3|
|TRA-1-60(S) (TRA-1-60(S)) Mouse mAb||100 tests||IF-IC||1:200||Mouse IgM|
|TRA-1-81 (TRA-1-81) Mouse mAb||100 tests||IF-IC||1:200||Mouse IgM|
The StemLight™ Pluripotency Antibody Kit contains a panel of antibodies for the detection of proteins that are specifically expressed in human pluripotent cells. The kit can be used to track the pluripotent potential of human embryonic stem (ES) or induced pluripotent (iPS) cells. The loss of these markers indicates a loss of pluripotency or differentiation of the culture. The kit components are pre-optimized for parallel use in immunofluorescent analysis. Enough reagents are provided for 100 assays based on a working volume of 100 µl.
Each antibody in the StemLight™ Pluripotency Antibody Kit detects endogenous levels of their respective human pluripotency marker proteins.
Nanog Antibody was produced by immunizing animals with a synthetic peptide corresponding to amino acid sequence at the amino terminus of human nanog. Antibodies are purified by Protein A and peptide affinity chromatography. Oct-4A antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human Oct-4A. Sox2 antibody is produced by immunizing animals with a synthetic peptide corresponding to amino acid sequences at the amino terminus of human Sox2. SSEA4, TRA-1-81, and TRA-1-60(S) antibodies are produced by immunizing animals with human embryonal carcinoma 2102Ep cl.2A6 cells.
Pluripotency is the ability of a cell to differentiate into cell types of the three germ layers, the endoderm, ectoderm and mesoderm. It is a property shared by embryonic stem cells, embryonic carcinoma and induced pluripotent cells.
Oct-4, Sox2 and Nanog are key transcriptional regulators that are highly expressed in pluripotent cells (1). Together they form a transcriptional network that maintains cells in a pluripotent state (2,3). Over-expression of Oct-4 and Sox2 along with Klf4 and c- Myc can induce pluripotency in both mouse and human somatic cells, highlighting their roles as key regulators of the transcrip- tional network necessary for renewal and pluripotency (4-5). It has also been demonstrated that overexpression of Oct-4, Sox2, Nanog and Lin28 can induce pluripotency in human somatic cells (6). Upon differentiation of pluripotent cultures, expression of Oct-4, Nanog and Sox2 is downregulated.
SSEA4, TRA-1-81 and TRA-1-60 antibodies recognize antigens expressed on the cell surface of all pluripotent cells. SSEA4 recognizes a glycolipid carbohydrate epitope (7). TRA-1-60(S) and TRA-1-81 antibodies recognize different proteoglycan epitopes on variants of the same protein, podocalyxin (8). These epitopes are neuraminadase sensitive and resistant, respectively. Reactivity of SSEA4, TRA-1-81 and TRA-1-60 antibodies with their respective cell surface markers are lost upon differentiation of pluripotent cells, corresponding with a loss of pluripotent potential (9).
Product Specific References
For Research Use Only. Not For Use In Diagnostic Procedures. Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc. StemLight™ is a trademark of Cell Signaling Technology, Inc. DRAQ5® is a registered trademark of Biostatus Limited. U.S. Patent No. 5,675,063.